International Flavors & Fragrances Inc. (IFF) Stock: Price, Forecast & Analyst Target
International Flavors & Fragrances Inc. (IFF) — MoonshotScore 54/100 (Fair band), calculated Oct 4, 2026. Price $82.42 (-0.84%), as of the Oct 2, 2026 trading session; market cap $21.0B. Expected results Nov 3, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 36.91× (market value Oct 2, 2026; cash Jun 30, 2026) · expected results Nov 3, 2026
International Flavors & Fragrances Inc. · IFF · NYSE · Basic Materials · Chemicals - Specialty
Research dated 2026-09-12: IFF designs ingredients that determine how food tastes, products smell, biological formulations perform, and medicines are manufactured; its customers are consumer-goods and pharmaceutical producers rather than end shoppers. The key test is whether the planned Food Ingredients divestiture can reduce leverage and sharpen the remaining portfolio without separation-related working-capital pressure overwhelming improving cash generation.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · International Flavors & Fragrances (IFF)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Strong price action running well ahead of the business — stalling growth underneath; a move to treat with suspicion, not chase. Business Quality: Average; Financial Safety: Okay; Valuation: Rich; Growth Durability: Shrinking; Momentum: Surging.
- quarterly revenue $1.95B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 5 of 8
- expected results Nov 3, 2026
Holding back: soft growth
Helping: positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 54 | Fair | |
| 55 | Fair | |
| 55 | Fair | |
| 55 | Fair | |
| 54 | Fair | |
| 54 | Fair |
The score moved from 53 in the stored Oct 3, 2026 snapshot to 54 in the current publication computed Oct 4, 2026 (+1).
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $82.42 | |
| Change on the day | -0.84% | |
| 52-week range | $59.14 – $89.32 | |
| Market capitalisation | $21.0B | |
| Price / earnings (trailing) | 75.61 | |
| Shares traded on the day | 1.85M | |
| Beta (volatility vs the S&P 500) | 0.95 | |
| Dividends per share (last 12 months) | $1.60 | |
| Dividend yield (last 12 months) | 1.94% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
We expect this transaction to close in the fourth quarter of 2026. We also announced our expected use of proceeds from the Food Ingredients divestiture through which we will strengthen our balance sheet and return capital to shareholders.
Jon Erik Fyrwald · Statement from
I do want to indicate that due to the Food Ingredients divestiture, we expect some net working capital headwinds in the second half of the year related to the separation and stand of that business.
Michael Deveau · Statement from
Chronological order, not a duration scale. Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsOther perspectives
Council score for International Flavors & Fragrances (IFF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 2, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the IFF film — every key number, told as a short cinematic story
~2 min · open the film
What is International Flavors & Fragrances (IFF), and what does it report?
Short answer · as of
Calling IFF a specialty chemicals company is incomplete.
Research dated 2026-09-12.
Calling IFF a specialty chemicals company is incomplete. Demand comes from manufacturers ordering flavor systems, fragrances, cosmetic actives, enzymes, cultures, probiotics, food-protection ingredients, and pharmaceutical excipients for specific formulations across food, personal care, household products, health, and medicine.
Reported sales span Food Ingredients, Taste, Scent, Health & Biosciences, and Pharma Solutions. Food Ingredients is the largest reported segment, Taste and Scent are similarly scaled, Health & Biosciences is another substantial operation, and Pharma Solutions is much smaller; this mix explains why consolidated revenue reflects several end markets rather than a uniform chemical cycle.
Annual sales declined in the latest completed year after barely changing in the prior year, while net income has swung between profits and substantial losses. Revenue scale has therefore been more stable than accounting profitability.
What do the latest results show for International Flavors & Fragrances (IFF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $1.95B.
Research dated 2026-09-12.
The latest quarter brought a sharp revenue step-down from the preceding period and from the comparable earlier period. Gross profit, operating profit, and net income remained positive but contracted sequentially, while the reported earnings comparison missed consensus after the preceding release exceeded expectations.
Cash generation moved in the opposite direction: operating cash flow strengthened and capital spending absorbed less cash than in the preceding period. Management separately expects growth in continuing operations and a favorable currency contribution, but it also anticipates working-capital pressure from separating Food Ingredients.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $1.95B Jun 30, 2026
- Latest quarter · R&D
- $170.00M Jun 30, 2026
- Latest quarter · SG&A
- $437.00M Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $158.00M Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $1.95B | $170.00M | $437.00M | $158.00M |
| Mar 31, 2026 | $2.74B | $166.00M | $427.00M | $279.00M |
| Dec 31, 2025 | $2.59B | $174.00M | $469.00M | $113.00M |
| Sep 30, 2025 | $2.69B | $174.00M | $421.00M | $226.00M |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $1.95B Aug 4, 2026
- Latest report · revenue estimate
- $2.62B Aug 4, 2026
- Latest report · revenue vs estimate
- Below estimate Aug 4, 2026
- Latest report · EPS vs estimate
- Below estimate Aug 4, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Aug 4, 2026 | $1.95B | $2.62B | $0.8200 | $1.0700 |
| May 5, 2026 | $2.74B | $2.64B | $1.2500 | $1.0700 |
| Feb 11, 2026 | $2.59B | $2.51B | $0.8000 | $0.8280 |
| Nov 4, 2025 | $2.69B | $2.63B | $1.0500 | $1.0200 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $1.95B | $50M | $0.19 (diluted) |
| Q1 FY2026 | $2.74B | $169M | $0.66 (diluted) |
| Q4 FY2025 | $2.59B | $31M | $0.07 (diluted) |
| Q3 FY2025 | $2.69B | $40M | $0.16 (diluted) |
What are the financial strengths and risks for International Flavors & Fragrances (IFF)?
Short answer
Cash and short-term investments were $569.00M at the Jun 30, 2026 balance-sheet date. Operating cash flow was $422.00M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-12.
IFF generates meaningful operating cash, and the latest period produced the strongest operating inflow in the displayed series while leaving positive cash after capital spending. Near-term liquidity ratios also indicate coverage of current obligations, although cash holdings have moved within a fairly narrow range after retreating from their recent peak.
Debt materially exceeds cash and investments, leaving the company in a substantial net-debt position. That makes the promised use of divestiture proceeds to strengthen the balance sheet consequential, especially because management expects the separation itself to consume working capital.
Profitability remains fragile: annual net results have repeatedly swung into losses, trailing margins and returns on capital are thin, and the latest quarter showed much less operating profit on lower sales. A prolonged revenue contraction, weaker cash conversion, or delayed debt reduction would place more pressure on a balance sheet already carrying limited cash relative to borrowings.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 1.63 sits in the distress zone (elevated bankruptcy risk).
- Rich valuation — a P/E of 75.61 runs well above the Basic Materials sector’s ~20.30x, leaving little room for a miss.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $422.00M Jun 30, 2026
- Previous quarter · operating cash flow
- $257.00M Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $422.00M | −$138.00M |
| Mar 31, 2026 | $257.00M | −$165.00M |
| Dec 31, 2025 | $318.00M | −$188.00M |
| Sep 30, 2025 | $164.00M | −$134.00M |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at International Flavors & Fragrances (IFF)?
Short answer · as of
The next earnings report is expected on Nov 3, 2026.
Research dated 2026-09-12.
Watch the Food Ingredients closing and the eventual division of proceeds between debt reduction and shareholder returns. Filings tied to material agreements make the transaction an active corporate event, while management's warning about separation-related working capital means the closing alone will not establish successful execution.
The operating test is whether continuing businesses deliver sales and earnings growth after separating the currency benefit. Consensus expects the next reported revenue to remain near the latest level, so progress in gross profit, operating profit, and earnings would need to come from the retained portfolio and its economics rather than a large immediate rebound in sales.
Cash conversion deserves equal weight. Sustained operating inflow after capital spending, followed by a visible reduction in net debt, would support management's balance-sheet plan; renewed cash erosion would weaken it.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
We expect this transaction to close in the fourth quarter of 2026. We also announced our expected use of proceeds from the Food Ingredients divestiture through which we will strengthen our balance sheet and return capital to shareholders.
Jon Erik Fyrwald ·
I do want to indicate that due to the Food Ingredients divestiture, we expect some net working capital headwinds in the second half of the year related to the separation and stand of that business.
Michael Deveau ·
On a continuing operations basis, we expect that foreign exchange will have roughly a 1 percentage point positive impact to sales growth and approximately 2% positive impact to EBITDA growth, both on a full year basis.
Michael Deveau ·
Our guidance for the full year, the range is 2% to 4% for sales and 4% to 8% for EBITDA.
Michael Deveau ·
How does International Flavors & Fragrances compare with its peers?
Short answer
International Flavors & Fragrances's score ranks tied for 11th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
IFF differs from a narrowly focused flavor or fragrance supplier because its portfolio reaches from food formulation and scent creation into enzymes, cultures, probiotics, cosmetic actives, and pharmaceutical excipients. Its revenue drivers therefore include product reformulation, preservation, sensory performance, biological functionality, and pharmaceutical manufacturing—not merely commodity chemical volume.
The divestiture removes the company's largest reported segment and leaves a business more concentrated in Taste, Scent, Health & Biosciences, and the smaller Pharma Solutions operation. That changes the comparison set: the remaining IFF will be judged increasingly on specialized formulation value and biological capabilities, while losing some of the breadth supplied by Food Ingredients.
| Company | Price | Market value | Score |
|---|---|---|---|
| $13.94 Oct 2, 2026 | $8.89B | 97 5-pillar Oct 4, 2026 | |
| $924.06 Oct 2, 2026 | $8.50B | 84 5-pillar Oct 4, 2026 | |
| $105.15 Oct 2, 2026 | $23.4B | 71 5-pillar Oct 4, 2026 | |
| $99.19 Oct 2, 2026 | $12.7B | 71 5-pillar Oct 4, 2026 | |
| $319.51 Oct 2, 2026 | $77.6B | 68 5-pillar Oct 4, 2026 | |
| $273.70 Oct 2, 2026 | $77.0B | 65 5-pillar Oct 4, 2026 | |
| $104.59 Oct 2, 2026 | $12.3B | 62 5-pillar Oct 4, 2026 | |
| $37.93 Oct 2, 2026 | $9.24B | 58 5-pillar Oct 4, 2026 | |
| $64.87 Oct 2, 2026 | $7.42B | 58 5-pillar Oct 4, 2026 | |
| $64.52 Oct 2, 2026 | $18.4B | 56 5-pillar Oct 4, 2026 | |
| International Flavors & Fragrances (IFF) — this page | $82.42 | $21.0B | 54 |
| $57.70 Oct 2, 2026 | $9.17B | 54 5-pillar Oct 4, 2026 | |
| $58.59 Oct 2, 2026 | $18.9B | 50 5-pillar Oct 4, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $91.00 – $100.00
- Consensus target
- $95.00
- Median target
- $95.00
Consensus record · Captured .
Measured against a quoted price of $82.42 (as of Oct 2, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Aug 17, 2026
- Transactions
- 69
- Identified insiders
- 16
- Purchases
- 2
- Sales
- 3
- Other transactions
- 64
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Reporting holders
- 771 Period end Jun 30, 2026
- Previous quarter · holders
- 719 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Dodge & Cox | 37,007,037 |
| Freemont Capital Pte Ltd | 25,356,381 |
| Blackrock, INC. | 23,175,401 |
| Vanguard Capital Management LLC | 16,255,207 |
| State Street Corp | 12,340,998 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about International Flavors & Fragrances (IFF)?
International Flavors & Fragrances Basic Materials Stock: Key Questions Answered
Research dated 2026-09-12; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
What does IFF sell beyond flavors and fragrances?
IFF also supplies food-protection systems, cosmetic actives, enzymes, cultures, probiotics, biological ingredients, and cellulosic or seaweed-derived pharmaceutical excipients. These products enter customer formulations across food, personal care, household, health, and pharmaceutical markets.
What changes when IFF divests Food Ingredients?
The sale removes IFF's largest reported segment, narrows the remaining mix toward Taste, Scent, Health & Biosciences, and Pharma Solutions, and provides proceeds that management expects to use for balance-sheet strengthening and shareholder returns. The transition may also pressure working capital during separation.
Why does IFF cash generation look stronger than its latest profit trend?
Operating cash flow rose sharply in the latest period even as revenue and accounting profit fell, and lower capital spending improved cash retained after investment. The divergence makes working-capital movements and cash conversion especially important in judging the underlying business.
Is IFF maintaining its dividend during the Food Ingredients separation?
The scheduled distribution matches the recent per-share payment pattern. Management has also said divestiture proceeds are intended partly for shareholder returns, although debt reduction remains another stated use.
What is the IFF stock price today?
The last price recorded on this page for International Flavors & Fragrances Inc. (IFF) is $82.42, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the IFF price target?
The analyst consensus price target for International Flavors & Fragrances Inc. (IFF) is $95.00 (range $91.00 to $100.00, median $95.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
When are IFF's next earnings?
The next earnings date listed on this page for International Flavors & Fragrances Inc. (IFF) is Nov 3, 2026. Companies sometimes move report dates, so the company's own announcement is the final word on timing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (83 figures)
The 83 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Jon Erik Fyrwald (Aug 5, 2026): We expect this transaction to close in the fourth quarter of 2026. We also announced our expected use of proceeds from the Food Ingredients divestiture through which we will strengthen our balance sheet and return capital to shareholders. Michael Deveau (Aug 5, 2026): I do want to indicate that due to the Food Ingredients divestiture, we expect some net working capital headwinds in the second half of the year related to the separation and stand of that business. Michael Deveau (Aug 5, 2026): On a continuing operations basis, we expect that foreign exchange will have roughly a 1 percentage point positive impact to sales growth and approximately 2% positive impact to EBITDA growth, both on a full year basis. Michael Deveau (Aug 5, 2026): Our guidance for the full year, the range is 2% to 4% for sales and 4% to 8% for EBITDA. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | NEW York, NY | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "521 West 57th Street, New York City, NY, 10019-2960, US". |
FMP — 70 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $82.42 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T20:54:52.793Z. | |
px.change | Change on the day | -0.84% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $21.0B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-04T20:54:51.778Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | −$0.70 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $1.95B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 75.61 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 1.85M | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.95 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Jon Erik Fyrwald | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 21,500 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $11.66B, net result $268.00M; FY2022 revenue $12.44B, net result −$1.87B; FY2023 revenue $11.48B, net result −$2.56B; FY2024 revenue $11.48B, net result $243.00M; FY2025 revenue $10.89B, net result −$361.00M | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Scent $2.48B · Taste $2.48B · Food Ingredients $3.28B · Pharma Solutions $369.00M · Health & Biosciences $2.28B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 37.5% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $1.95B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.rd_k | R&D — period end 2026-06-30 | $170.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $437.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | $158.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $2.74B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.rd_k | R&D — period end 2026-03-31 | $166.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $427.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $279.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $2.59B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.rd_k | R&D — period end 2025-12-31 | $174.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $469.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $113.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $2.69B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.rd_k | R&D — period end 2025-09-30 | $174.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $421.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $226.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-08-04.revenue_actual | Revenue · reported — report date 2026-08-04 | $1.95B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-04.revenue_estimated | Revenue · estimate — report date 2026-08-04 | $2.62B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-04.eps_actual | EPS · reported — report date 2026-08-04 | $0.8200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-04.eps_estimated | EPS · estimate — report date 2026-08-04 | $1.0700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-05.revenue_actual | Revenue · reported — report date 2026-05-05 | $2.74B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-05.revenue_estimated | Revenue · estimate — report date 2026-05-05 | $2.64B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-05.eps_actual | EPS · reported — report date 2026-05-05 | $1.2500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-05.eps_estimated | EPS · estimate — report date 2026-05-05 | $1.0700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.revenue_actual | Revenue · reported — report date 2026-02-11 | $2.59B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.revenue_estimated | Revenue · estimate — report date 2026-02-11 | $2.51B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.eps_actual | EPS · reported — report date 2026-02-11 | $0.8000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.eps_estimated | EPS · estimate — report date 2026-02-11 | $0.8280 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.revenue_actual | Revenue · reported — report date 2025-11-04 | $2.69B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.revenue_estimated | Revenue · estimate — report date 2025-11-04 | $2.63B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.eps_actual | EPS · reported — report date 2025-11-04 | $1.0500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.eps_estimated | EPS · estimate — report date 2025-11-04 | $1.0200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $569.00M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $422.00M | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $10.00M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $6.24B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 1.51× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $422.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $257.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$138.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$165.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $318.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$188.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $164.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | −$134.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $91.00 – $100.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $95.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $95.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 69 transactions · 2 purchases, 3 sales, 64 other transactions · 16 identified insiders · of the newest 100 records, those within the last 180 days, newest dated Aug 17, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.holders | Reporting holders | 771 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 719 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Dodge & Cox — shares in provider snapshot | 37,007,037 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Freemont Capital Pte Ltd — shares in provider snapshot | 25,356,381 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Blackrock, INC. — shares in provider snapshot | 23,175,401 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Vanguard Capital Management LLC — shares in provider snapshot | 16,255,207 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | State Street Corp — shares in provider snapshot | 12,340,998 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Nov 3, 2026 | UNRECORDED | Stored earnings-calendar observation — Captured 2026-09-30 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 5 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-04 | |
px.range52 | 52-week range | $59.14 – $89.32 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Altman Z 1.63 · Piotroski F 7 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 36.91× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $569.00M at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-02. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $1.60 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 1.94% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-08-04.revenue_actual.comparison | Latest report · revenue vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($1.95B) with the recorded estimate ($2.62B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-08-04.eps_actual.comparison | Latest report · EPS vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.8200) with the recorded estimate ($1.0700) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 54 of 100 · Fair · pillars 53 / 43 / 38 / 17 / 82 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 53 (stored snapshot Oct 3, 2026) → 54 (current publication computed Oct 4, 2026) (+1) | OURS | Stock Expert AI current score publication and immutable score snapshots |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.rd_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.rd_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.rd_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.rd_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-08-04. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-08-04.revenue_actual,earn.history.depth.2026-08-04.revenue_estimated,earn.history.depth.2026-08-04.revenue_actual.comparison,earn.history.depth.2026-08-04.eps_actual.comparison,earn.history.depth.2026-08-04.eps_actual,earn.history.depth.2026-08-04.eps_estimated,earn.history.depth.2026-05-05.revenue_actual,earn.history.depth.2026-05-05.revenue_estimated,earn.history.depth.2026-05-05.eps_actual,earn.history.depth.2026-05-05.eps_estimated,earn.history.depth.2026-02-11.revenue_actual,earn.history.depth.2026-02-11.revenue_estimated,earn.history.depth.2026-02-11.eps_actual,earn.history.depth.2026-02-11.eps_estimated,earn.history.depth.2025-11-04.revenue_actual,earn.history.depth.2025-11-04.revenue_estimated,earn.history.depth.2025-11-04.eps_actual,earn.history.depth.2025-11-04.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-12
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Scent: $2.48B; Taste: $2.48B; Food Ingredients: $3.28B; Pharma Solutions: $369.00M; Health & Biosciences: $2.28B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-08-05 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash, investments and debt | Total debt: $6.24B; Liquidity basis: cash and short-term investments; Total liabilities: $11.14B; Cash and short-term investments: $569.00M; Cash and investments: $579.00M; Long-term investments: $10.00M; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Sector / industry (provider taxonomy) | Basic Materials / Chemicals - Specialty The company's SEC filings classify it under SIC 2860 — Industrial Organic Chemicals. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-08-04 | FMP | Financial Modeling Prep (FMP) earnings |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $579.00M; Cash and short-term investments: $569.00M; Long-term investments: $10.00M; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash against market value | As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$5.67B; Total debt: $6.24B; Cash and investments: $569.00M Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-06-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Trailing twelve-month ratio set | Quick ratio: 1.72; Current ratio: 2.06; Debt to equity: 0.45; Net margin: 2.9%; Gross margin: 37.5%; Operating margin: 7.8%; Return on assets: 1.2%; Return on equity: 2.1% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Distress and quality screens | Altman Z-score: 1.66; Piotroski F-score: 7 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) financial scores |
| Recent SEC filings |
| 2026-08-04 | OFFICIAL | SEC EDGAR filer submissions |
| Most recent periodic reports | Annual: Document: https://www.sec.gov/Archives/edgar/data/51253/000005125326000006/iff-20251231.htm, Filed: 2026-02-27, Period end: 2025-12-31; Quarterly: Document: https://www.sec.gov/Archives/edgar/data/51253/000005125326000030/iff-20260630.htm, Filed: 2026-08-04, Period end: 2026-06-30 | 2026-08-04 | OFFICIAL | SEC EDGAR filer submissions |
| Next earnings report | Date: 2026-11-03; EPS estimate: $0.8 per share; Revenue estimate: $1.90B The date is our provider's estimate until the company confirms it. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-12 | FMP | Financial Modeling Prep (FMP) analyst estimates |
| Next scheduled dividend | Ex date: 2026-09-18; Declared on: 2026-07-28; Record date: 2026-09-18; Payment date: 2026-10-09; Amount per share: $0.4 Amount is per share as declared, before any withholding. Owning the share before the ex-date is what carries entitlement. | 2026-07-28 | FMP | Financial Modeling Prep (FMP) dividend calendar |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-06-18 | FMP | Financial Modeling Prep (FMP) dividend history |
Data provided for informational purposes only.